AI-generated summary
The authors report a follow-up study of 68 patients who received intravascular red light therapy alongside coronary stenting, with angiographic restudy in 61 patients. Restenosis was found in 14.7 percent of those restudied, rising sharply in smaller arteries. The authors conclude the therapy was safe, feasible and reduced restenosis in arteries larger than 2.5 mm, though the abstract reports no control group for comparison.
- Participants
- 68
- Who or what was studied
- 68 patients undergoing coronary stenting, mean age 64 +/- 9 years, with 61 receiving angiographic restudy
- Limits stated in the abstract
- The abstract reports no control group, so the restenosis reduction cannot be compared directly against untreated patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.